期刊
CHINESE MEDICINE
卷 15, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13020-020-00359-1
关键词
Alzheimer's disease; Pathogenic hypothesis; Berberine; Evodiamine; Traditional Chinese medicine
资金
- Natural Science Foundation of Ningbo [2017A610258]
- National Natural Science Foundation of China [U1503233, 81603266]
- K.C. Wong Magna Fund at Ningbo University
Alzheimer's disease (AD) is one of the most common diseases in elderly people with a high incidence of dementia at approximately 60-80%. The pathogenesis of AD was quite complicated and currently there is no unified conclusion in the academic community, so no efficiently clinical treatment is available. In recent years, with the development of traditional Chinese medicine (TCM), researchers have proposed the idea of relying on TCM to prevent and treat AD based on the characteristic of multiple targets of TCM. This study reviewed the pathological hypothesis of AD and the potential biomarkers found in the current researches. And the potential targets of berberine and evodiamine from Evodia rutaecarpa in AD were summarized and further analyzed. A compound-targets-pathway network was carried out to clarify the mechanism of action of berberine and evodiamine for AD. Furthermore, the limitations of current researches on the TCM and AD were discussed. It is hoped that this review will provide some references for development of TCM in the prevention and treatment of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据